Stratasys Ltd.
—- Market cap
- —
- Debt
- +$196.36M
- Cash
- −$94.53M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $2.81B
Decision snapshot: SSYS stock price vs ALHC: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ALHC's multiple
Needs EPS (TTM), ALHC P/E.
Implied fair value · at SSYS's multiple
Needs EPS (TTM) is negative, SSYS P/E.
Metric by metric
Snapshot Sep 4, 4:00 PM ET
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: SSYS FY 2025 (ended Dec 31, 2025) · ALHC FY 2025 (ended Dec 31, 2025).
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 90% equity / 10% debt · EV / Revenue 0.64x · EV / EBITDA 53.89x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
STRATASYS LTD. · implied price per share
The ordinary-share to listed-security ratio could not be verified.
ALIGNMENT HEALTHCARE, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.23x
1.80x
Net debt / EBITDA
Leverage against operating earnings
-1.75x
-5.99x
Cash and equivalents
Liquid reserves on the balance sheet
$94.53M
$604.23M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Nano Dimension Ltd.
SSYS vs NNDM
HP INC
SSYS vs HPQ
Proto Labs Inc
SSYS vs PRLB
3D SYSTEMS CORP
SSYS vs DDD
Cigna Group
SSYS vs CI
MOLINA HEALTHCARE, INC.
SSYS vs MOH
Elevance Health, Inc.
SSYS vs ELV
CENTENE CORP
SSYS vs CNC
UNITEDHEALTH GROUP INC
SSYS vs UNH
CLOVER HEALTH INVESTMENTS, CORP. /DE
SSYS vs CLOV
$196.36M
$323.18M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.